An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
Assiut University, Assiut, Egypt
Kocaeli University, Kocaeli, Turkey
Department of Spine Diseases and Pediatric Orthopedics, University of Medical Sciences, Poznań, Poland, Poznań, Wielkopolska, Poland
Sohag University Hospital, Sohag, Egypt
Minya University Faculty of Medicine, Minya, Egypt
Tongji hospital, Wuhan, Hubei, China
Assiut University, Assiut, Egypt
Mental Health Center Copenhagen, Bispebjerg, Copenhagen N, Denmark
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.